ArticleHeliyon2025
Preoperative prediction of multiple biological characteristics in colorectal cancer using MRI and machine learning.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging andJournal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is the second most prevalent cause of oncological mortality, and its diagnostic and therapeutic decision-making processes is complex. Alteration in molecular characteristic expression is closely related to tumor invasiveness and can serve a novel biomarker for predicting cancer prognosis. In this study, we aimed to construct radiomic models through machine learning to predict the progression of CRC. We collected the clinical, pathological, and magnetic resonance imaging (MRI) data of 136 CRC patients who underwent direct surgical resection. Immunohistochemistry analysis was performed to detect the expression levels of p53, synaptophysin (Syn), human epidermal growth factor receptor 2 (HER2), perineural invasion (PNI), and vascular invasion (VI) expression levels in CRC tissues. After the manual lesion segmentation, 1781 radiomics features were extracted from the transverse T2-weighted image of MRI (T2W-MRI). We employed Spearman's rank correlation coefficient, greedy recursive deletion strategy, minimum redundancy, maximum relevance, least absolute shrinkage, and selection operator regression were utilized to screen for radiological features. Radiomics and clinical models were constructed using the K-nearest neighbor (KNN). The diagnostic efficiencies of the prediction models were evaluated using receiver operating characteristic curves and quantified employing the area under the curve (AUC). Our research results indicate that compared with the single radioactive model, the clinical radiomics model in the validation cohort showed better diagnostic performance, as indicated by the AUC values (p53 = 0.758, Syn = 0.739, HER2 = 0.786, PNI = 0.835, VI = 0.797). Furthermore, the calibration curve and decision curve analyses showed the clinical benefits. In summary, we developed and validated a clinical radiomics model to preoperative prediction of the biological characteristic expression levels of CRC. The findings of this research may offer a promising noninvasive method for evaluating CRC risk stratification and may lay the groundwork for treatment of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.